George Badescu, PhDChief Business Officer at Heidelberg PharmaSpeaker
Profile
Dr George Badescu is Chief Business Officer at Heidelberg Pharma and has over 15 years of experience in the biotechnology sector. He most recently served as Vice President Scientific Affairs at Abzena Plc where he led the scientific promotion and commercialization of Abzena’s Technologies and Chemistry Research and Manufacturing Services. Prior to this, he led PolyTherics’ Antibody Drug Conjugates (ADCs) program since its inception and is co-inventor on several patents in the field of bioconjugation and ADCs. Prior to this, George has worked on lead identification by viral display technologies, antibody engineering and characterisation of antibody-hapten interactions. George received his PhD from the University of Warwick.
Agenda Sessions
From Bench to Oncology Therapies: The Evolution of Amanitin-based ADCs and Why the Payload Makes the Difference
, 16:45View Session